Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

CRO Tigermed Strikes Deal with Biostatistician MacroStat

publication date: Mar 3, 2009

China CRO Tigermed Consulting Co., Ltd. (泰格医药科技有限公司) and MacroStat, a CRO offering clinical data management and statistical analysis, seem to be edging closer together. They have not merged, nor have they declared a formal relationship. Instead, the official word is that Tigermed and Qiming Venture, the VC firm that put $5 million into Tigermed in July 2008, will “join hands to grant asset injection to MacroStat.” More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital